nt pharma (01011.HK) issued a statement on the infrequent price fluctuation, the company is considering issuing new shares to four creditors (including two major shareholders), aiming to capitalize the existing principal amount and interest owed to the group's subscriber. If implemented, it will result in any subscriber holding more than 30% of the company's shares, triggering the mandatory general offer obligation as required by law.

The company's shares have applied for trading resumption on Thursday (10th).